Staphylococcus aureus enterotoxin B regulates prostaglandin E2 synthesis, growth, and migration in nasal tissue fibroblasts.
BACKGROUND
Superantigens and eicosanoids are important amplifiers and regulators of inflammation in airway diseases. We therefore studied the possible influence of Staphylococcus aureus enterotoxin B (SEB) on the cyclooxygenase (COX) pathway and basic functions of airway structural cells.


METHODS
Fibroblasts were isolated from nasal inferior turbinate tissue and cultured in the presence of different concentrations of SEB. Preincubation with interferon (IFN)-gamma was performed to induce expression of major histocompatibility complex (MHC) class II receptors. Prostaglandin E2 (PGE(2)) production was assayed by enzyme-linked immunosorbent assay, and levels of COX-2 and prostanoid E receptors 1-4 (EP(1-4)) were assayed by real-time polymerase chain reaction. Migration and growth tests were performed, and SEB was localized within the cells by confocal microscopy.


RESULTS
Stimulation with IFN-gamma and SEB significantly down-regulated PGE(2), COX-2, and EP(2) expression but not EP(1), EP(3), or EP(4) expression. The enterotoxin blocked cell growth but increased the fibroblast migration rate. SEB was localized within the cell in the presence and absence of MHC-II, suggesting that mechanisms other than conventional binding may allow the enterotoxin to enter the cell.


CONCLUSIONS
These findings may have major implications for our understanding of the role played by bacterial superantigens in regulating the inflammatory and remodeling mechanisms of upper airway diseases and hence may help elucidate the pathophysiology of these diseases.
Pérez-Novo
Claudina A
CA
Upper Airways Research Laboratory, Department of Otorhinolaryngology, Ghent University Hospital, Belgium. claudina.Pereznovo@UGent.be
Waeytens
Anouk
A
Claeys
Cindy
C
Cauwenberge
Paul Van
PV
Bachert
Claus
C
D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation; D002478:Cells, Cultured; D051546:Cyclooxygenase 2 / Q000096:biosynthesis; D015232:Dinoprostone / Q000096:biosynthesis*; D004768:Enterotoxins / Q000633:toxicity*; D004797:Enzyme-Linked Immunosorbent Assay; D005347:Fibroblasts / Q000737:chemistry / Q000187:drug effects*; D020869:Gene Expression Profiling; D006801:Humans; D018613:Microscopy, Confocal; D018078:Receptors, Prostaglandin E / Q000096:biosynthesis; D020133:Reverse Transcriptase Polymerase Chain Reaction
D004768:Enterotoxins; D018078:Receptors, Prostaglandin E; C031818:enterotoxin B, staphylococcal; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D015232:Dinoprostone